Ammifurin

Ammifurin: description, use, side effects and contraindications

Ammifurin is a photosensitizing drug containing a mixture of three furocoumarins: isopimpinellin, bergapten and xanthotoxin, obtained from the seeds of Ammi major. The drug is produced by several companies, including Vilar and GNIISKLS, in Russia.

Ammifurin is available in several forms: substance, tablets in a dosage of 20 mg and solution in a concentration of 0.3%. It is used to treat two skin diseases: vitiligo and alopecia areata.

Vitiligo is a chronic skin disease that causes loss of pigment and the appearance of white patches on the skin. Pattern baldness is an autoimmune disease in which hair falls out in patches on the scalp.

Contraindications to the use of Ammifurin include hypertension, thyrotoxicosis, diseases of the kidneys, liver, blood, heart, central nervous system, malignant and benign tumors, pregnancy. It is not recommended to prescribe the medicine to children under 5 years of age and people over 60 years of age.

Side effects of Ammifurin may include headache, pain in the heart and palpitations, and dyspeptic symptoms.

The interaction of Ammifurin with other drugs is unknown.

Overdose with Ammifurin has not been described in the literature.

During treatment with Ammifurin, it is recommended to wear sunglasses during the daytime to avoid skin burns from sunlight.

In conclusion, Ammifurin is an effective photosensitizing drug used to treat vitiligo and alopecia areata. However, before starting treatment, you should definitely consult your doctor to find out about contraindications and possible side effects.